Ischemic stroke in anti-phospholipase A2 receptor antibody-positive primary membranous nephropathy: clinical and neuroimaging characteristics

被引：3
|
作者：
ZhangJing
ShuJun-Long
YouQian
ZhangWei
HuangYi-Ning
机构：
[1] Beijing100034
[2] China.DepartmentofNeurology
[3] DepartmentofNeurology
[4] PekingUniversityFirstHospital
来源：
中华医学杂志(英文版) | 2020年 / 133卷 / 03期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
<正>Primary membranous nephropathy (PMN) is the most common cause of nephrotic syndrome in adults. Most patients with PMN have circulating immunoglobulin G4 autoantibody to the podocyte membrane antigen p
引用
收藏
页码：361 / 362-363
相关论文
共 50 条
  • [21] Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
    Chao Li
    Hang Li
    Yu-bing Wen
    Xue-mei Li
    Xue-wang Li
    BMC Nephrology, 19
  • [22] Anti-Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy
    Kattah, A.
    Ayalon, R.
    Beck, L. H., Jr.
    Sethi, S.
    Sandor, D. G.
    Cosio, F. G.
    Gandhi, M. J.
    Lorenz, E. C.
    Salant, D. J.
    Fervenza, F. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (05) : 1349 - 1359
  • [23] Anti-Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
    Timmermans, Sjoerd A. M. E. G.
    Ayalon, Rivka
    van Paassen, Pieter
    Beck, Laurence H., Jr.
    van Rie, Henk
    Wirtz, Joris J. J. M.
    Verseput, Gaico H.
    Frenken, Leon A.
    Salant, David J.
    Tervaert, Jan Willem Cohen
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (06) : 1223 - 1225
  • [24] Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
    Fu, Keying
    Zhang, Pei
    Han, Yeguang
    Wang, Ru
    Cai, Junhong
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2022, 2022
  • [25] Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
    Barrett, Christine
    Willcocks, Lisa C.
    Jones, Rachel B.
    Tarzi, Ruth M.
    Henderson, Robert B.
    Cai, Gengqian
    Gisbert, Sophie, I
    Belson, Alexandra S.
    Savage, Caroline O.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (04) : 599 - 606
  • [26] Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A2 receptor antibody-positive idiopathic membranous nephropathy: a case report
    Iio, Rei
    Akiyama, Shin'ichi
    Mitsumoto, Kensuke
    Iwata, Yukimasa
    Okushima, Hiroki
    Shimada, Karin
    Ota, Naomi
    Tomida, Kodo
    Fushimi, Hiroaki
    Shoji, Tatsuya
    Matsumoto, Masanori
    Hayashi, Terumasa
    BMC NEPHROLOGY, 2020, 21 (01)
  • [27] Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy
    Hofstra, Julia M.
    Beck, Laurence H., Jr.
    Beck, David M.
    Wetzels, Jack F.
    Salant, David J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1286 - 1291
  • [28] Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A2 receptor antibody-positive idiopathic membranous nephropathy: a case report
    Rei Iio
    Shin’ichi Akiyama
    Kensuke Mitsumoto
    Yukimasa Iwata
    Hiroki Okushima
    Karin Shimada
    Naomi Ota
    Kodo Tomida
    Hiroaki Fushimi
    Tatsuya Shoji
    Masanori Matsumoto
    Terumasa Hayashi
    BMC Nephrology, 21
  • [29] Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
    Stefan, Gabriel
    Stancu, Simona
    Zugravu, Adrian
    Popa, Otilia
    Zubidat, Dalia
    Petre, Nicoleta
    Mircescu, Gabriel
    RENAL FAILURE, 2022, 44 (01) : 258 - 268
  • [30] PROGNOSTIC ROLE OF ANTI-PHOSPHOLIPASE A2 RECEPTOR ANTIBODY NEGATIVIZATION AT THREE MONTHS IN MEMBRANOUS NEPHROPATHY
    Stefan, Gabriel
    Stancu, Simona
    Popa, Otilia
    Zugravu, Adrian Dorin
    Petre, Nicoleta
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345